Kevin Lee, Bicycle Therapeutics CEO
September 9, 2024 10:34 AM EDTUpdated September 11, 11:13 AM
R&D

Bi­cy­cle Ther­a­peu­tics makes an ear­ly case for its Pad­cev com­peti­tor: #ES­MO24

Lei Lei Wu

News Reporter

Bi­cy­cle Ther­a­peu­tics dis­closed in an ab­stract Sun­day that 45% of blad­der can­cer pa­tients re­spond­ed to its ex­per­i­men­tal treat­ment in an ear­ly-stage study.

In 38 pa­tients …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Chi­nese drug­mak­er re­ceives FDA warn­ing let­ter af­ter man­age­ment hin­dered in­spec­tion

GSK plots reg­u­la­to­ry fil­ings for PBC itch af­ter pos­i­tive Phase 3 read­out

Bio­gen, UCB de­tail re­sponse rates in Phase 3 lu­pus tri­al af­ter sur­pris­ing suc­cess

J&J, Pro­tag­o­nist re­veal two Phase 3 wins for oral IL-23 drug that's ex­pect­ed to be a block­buster

FDA re­jects Astel­las’ ef­fort to sup­port longer use of eye drug Iz­er­vay 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times